The Inkey List Succinic Acid Acne Treatment

Description

No specific description details are available for SPL code 34089-3.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic or nonteratogenic effects mentioned associated with the use of this medication.

Dosage and Administration

Healthcare professionals are advised to ensure that the skin is thoroughly cleaned prior to the application of this product. The affected area should be covered with a thin layer of the product, applied one to three times daily.

Initial treatment should commence with one application per day. Based on the patient's response and as directed by a physician, the frequency may be gradually increased to two or three times daily.

In cases where bothersome dryness or peeling occurs, it is recommended to reduce the application frequency to once daily or every other day to mitigate these effects.

Contraindications

There are no specified contraindications for the use of this product. However, it is advised to avoid contact with the eyes to prevent potential irritation or adverse effects.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to avoid simultaneous use of this product with other topical acne medications, as this may increase the likelihood of skin irritation and dryness. In the event that irritation occurs, it is recommended to limit the use to one topical acne medication at a time to mitigate adverse effects.

In cases of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Should the product come into contact with the eyes, it is imperative to flush the area thoroughly with water. Healthcare providers should emphasize the importance of avoiding contact with the eyes to prevent potential complications.

Side Effects

Patients using this product may experience skin irritation and dryness, particularly if another topical acne medication is used concurrently. It is advised that only one topical acne medication be utilized at a time to minimize the risk of irritation.

This product is intended for external use only. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately. If the product comes into contact with the eyes, it is important to flush the area thoroughly with water to mitigate potential harm.

Care should be taken to keep this product out of reach of children to prevent accidental ingestion or contact.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be utilized at a time. If irritation does occur, discontinuation of all but one topical agent is recommended to allow the skin to recover and to minimize adverse effects. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of The Inkey List Succinic Acid Acne Treatment (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is recommended.

When treating pediatric patients with this product, caution is advised regarding the concurrent use of other topical acne medications, as this may increase the likelihood of skin irritation and dryness. If irritation occurs, it is recommended to limit the use to one topical acne medication at a time.

To minimize the risk of excessive skin drying, it is advisable to initiate treatment with one application daily. The frequency may be gradually increased to two or three times daily as needed or as directed by a healthcare professional. Should bothersome dryness or peeling develop, the application frequency should be reduced to once daily or every other day.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information available regarding the use of this drug during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment and the need to inform their healthcare provider if they become pregnant or plan to become pregnant while using this medication.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific information is available.

Renal Impairment

There is no information available regarding renal impairment, including dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of specific guidance when treating patients with renal impairment.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the individual patient's liver status when prescribing this medication.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are advised to ensure patient safety and effective management of any complications that may arise from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the medication is swallowed. It is important to emphasize the need for prompt action in such situations.

Patients should be instructed to flush the affected area thoroughly with water if contact with the skin occurs. Additionally, healthcare providers should caution patients to avoid contact with the eyes, as this can lead to further complications.

Providers should inform patients that using this medication in conjunction with other topical acne treatments may increase the likelihood of skin irritation and dryness. Therefore, if patients experience any irritation, they should be advised to limit their use to one topical acne medication at a time to minimize adverse effects.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product within the recommended temperature range, avoiding extremes below 40°F and above 100°F to maintain its integrity and efficacy. Proper container requirements should be adhered to, ensuring that the product is kept in a suitable environment. Special handling needs must be observed to prevent any compromise to the product's quality.

Additional Clinical Information

The route of administration for the medication is topical. Clinicians should advise patients that if irritation occurs, they should limit the use to one topical acne medication at a time. In cases of bothersome dryness or peeling, patients are recommended to reduce the application frequency to once a day or every other day.

Drug Information (PDF)

This file contains official product information for The Inkey List Succinic Acid Acne Treatment, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)